Rubio Demands Biden-harris Admin Stop Importation of Slave-made Pharmaceuticals
October 31, 2024
October 31, 2024
WASHINGTON, Oct. 31 -- Sen. Marco Rubio, R-Florida, issued the following news release:
Despite the passage of the Rubio-led Uyghur Forced Labor Prevention Act (UFLPA) in 2021, a recent report has revealed that two Xinjiang-based pharmaceutical entities continue to exploit American laws for profit. To uphold the UFLPA, the U.S. Food and Drug Administration (FDA) and U.S. Department of Homeland Security (DHS) must swiftly add Xinjiang Nuziline Bio-Pharmaceutical Co. and SEL Biochem Xi . . .
Despite the passage of the Rubio-led Uyghur Forced Labor Prevention Act (UFLPA) in 2021, a recent report has revealed that two Xinjiang-based pharmaceutical entities continue to exploit American laws for profit. To uphold the UFLPA, the U.S. Food and Drug Administration (FDA) and U.S. Department of Homeland Security (DHS) must swiftly add Xinjiang Nuziline Bio-Pharmaceutical Co. and SEL Biochem Xi . . .